Flagship explainer

How CYTEK BIOSCIENCES, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$201M · 100%Cost of revenue$97M · 48%Gross profit$104M · 52%Operating income−$40.4M · −20%Income before tax−$29.8M · −15%Income tax$36.7M · 18%Net income−$66.5M · −33%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$201M100%
Cost of revenue$97M48%
$104M52%
−$40.4M−20%
Income before tax−$29.8M−15%
Income tax$36.7M18%
−$66.5M−33%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full CYTEK BIOSCIENCES, INC. analysis at Buy Like Buffett

CTKB income explainer — Buy Like Buffett · Buy Like Buffett